https://doi.org/10.4081/monaldi.2005.648

Pulmonary involvement in systemic sclerosis due to therapy and as a complication

Vol. 63 No. 2 (2005): Pulmonary series
Submitted: February 18, 2016
Accepted: February 18, 2016
Published: June 30, 2005
Systemic sclerosis, bronchiolitis, penicillamine, pulmonary hypertension
Abstract Views: 441
PDF: 387
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

F. Chiappini
fabrizio.chiappini@fastwebnet.it
Divisione di Pneumologia, Università Cattolica del Sacro Cuore, Roma, Italy.
A. Zoli
Divisione di Reumatologia,, Università Cattolica del Sacro Cuore, Roma, Italy.
L. Maugeri
Divisione di Pneumologia, Università Cattolica del Sacro Cuore, Roma, Italy.
(SS), similar to other connective tissue diseases. Sometimes lung disease may be a side effect of antirheumathic drugs. We report a case of a patient affected by SS, with isolated pulmonary hypertension, who developed bronchiolitis secondary to penicillamine. The latter was treated by withdraw of the drug without increasing the steroids. After one month, the patient’s clinical conditions appeared improved.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Chiappini, F., A. Zoli, and L. Maugeri. 2005. “Pulmonary Involvement in Systemic Sclerosis Due to Therapy and As a Complication”. Monaldi Archives for Chest Disease 63 (2). https://doi.org/10.4081/monaldi.2005.648.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.